G542-1312 Screening compound: 5-[(4-chlorophenyl)methyl]-N-{2-[4-(methylsulfanyl)phenyl]ethyl}-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-2-carboxamide

G542-1312 Screening compound: 5-[(4-chlorophenyl)methyl]-N-{2-[4-(methylsulfanyl)phenyl]ethyl}-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-2-carboxamide
G542-1312 Screening compound: 5-[(4-chlorophenyl)methyl]-N-{2-[4-(methylsulfanyl)phenyl]ethyl}-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G542-1312
5-[(4-chlorophenyl)methyl]-N-{2-[4-(methylsulfanyl)phenyl]ethyl}-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G542-1312

Molecular Formula

C24H25ClN4O2S (C24 H25 ClN4 O2 S)

Compound Name

5-[(4-chlorophenyl)methyl]-N-{2-[4-(methylsulfanyl)phenyl]ethyl}-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-2-carboxamide

IUPAC name

5-[(4-chlorophenyl)methyl]-N-{2-[4-(methylsulfanyl)phenyl]ethyl}-4-oxo-4H5H6H7H8H-pyrazolo[15-a][14]diazepine-2-carboxamide

SMILES

CSc1ccc(CCNC(c2nn(CCCN(Cc(cc3)ccc3Cl)C3=O)c3c2)=O)cc1

InChI

InChI=1S/C24H25ClN4O2S/c1-32-20-9-5-17(6-10-20)11-12-26-23(30)21-15-22-24(31)28(13-2-14-29(22)27-21)16-18-3-7-19(25)8-4-18/h3-10,15H,2,11-14,16H2,1H3,(H,26,30)

InChI Key

NJROCXROAVYOTD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15017872

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

469.01

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.740

Distribution Coefficient, logD

3.740

Water Solubility, LogSw

-4.34

Polar Surface Area

54.636

Acid Dissociation Constant (pKa)

12.83

Base Dissociation Constant (pKb)

-2.37

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.20

G542-1312 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with G542-1312 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G542-1312?
Check Price and Availability of G542-1312, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G542-1312 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G542-1312
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G542-1312
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G542-1312 available by request